Purchase Order 75F40123P00227
Award Date 7/12/23
Potential Completion Date 8/21/24
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
- The Department of Health and Human Services Food and Drug Administration awarded a $533,378 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for delivery of one Illumina NextSeq 2000 Sequencing System to support the agency's microbial metagenomics research in Berwyn Heights, Maryland. The original solicitation requested an integrated genomic sequencing system, including the NextSeq 2000 or equivalent, to generate sequence data, perform real-time...
- The Food and Drug Administration awarded a $138,938.83 firm fixed-price delivery order to Illumina, Inc. on November 19, 2014, for MiSeq reagents, with a completion date of December 31, 2014. This delivery order, which carries no set-aside designation, represents procurement of consumable reagent kits for the MiSeq DNA sequencing platform. The award to the San Diego-based biotechnology company reflects FDA's reliance on Illumina's specialized genetic sequencing technologies to support the...
- The Food and Drug Administration awarded a $996,000 firm fixed-price delivery order to Illumina, Inc. for a MiSeq Sequencer and associated reagents on September 15, 2014, with an ultimate completion date of September 13, 2017. The award was issued to the San Diego-based biotechnology company without set-aside designation, reflecting Illumina's specialized position as the primary provider of next-generation DNA and RNA sequencing technologies to federal agencies. The delivery order procures...
- The Department of Health and Human Services Food and Drug Administration awarded a $287,793 firm fixed price definitive contract to Illumina, Inc. to deliver three genome sequencers or equivalent solutions. The solicitation requested quotes for genome sequencers to be used by FDA regulatory laboratories for analyzing medical products and food samples. Illumina will provide the equipment within 90 days of award along with one year of warranty coverage, monthly status reports, and training....
- The Department of Health and Human Services Food and Drug Administration awarded a $67,963.80 firm fixed price purchase order to Illumina, Inc. for corrective, remedial, repair, and preventive maintenance services for Illumina's MiSeq sequencing systems. The contract has a period of performance through February 28, 2025 and was awarded on December 12, 2019. No set-aside designation was used for this award to support the FDA's medical device evaluation programs through ongoing maintenance and...
- This federal contract award by the Department of Health and Human Services Food and Drug Administration adds $110,510.96 in funding to an original requisition with Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is a firm fixed price Delivery Order with no set-aside designation. Illumina has previously provided sequencing systems, consumables, and support services to various government agencies for research and diagnostics. This award likely supports...
- The Department of Health and Human Services Food and Drug Administration awarded a $19,283.10 firm fixed price purchase order to Illumina, Inc. to provide Illumina ISEQ 100 Systems. The ISEQ 100 Systems will be used for quality control and rebalancing of samples in sample pools. The systems are compatible with Illumina's library preparation kits and provide fast, cost-effective small-scale runs. The place of performance is Illumina's facilities in San Diego, California, and the period of...
- The Food and Drug Administration awarded a delivery order valued at $124.5K to Illumina, Inc. for preventative maintenance services on a MiSeq benchtop sequencer. This firm fixed-price delivery order, issued on November 12, 2014, with an ultimate completion date of December 5, 2015, represents a critical support service for FDA laboratory operations in San Diego, California. The award carries no set-aside designation, reflecting Illumina's specialized position as the manufacturer of the...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide an Illumina MiniSeq DNA/RNA Next Generation Sequencer (NGS) device plus four years of post-warranty maintenance support. The total potential value of the contract is $86,106.00. This procurement was not set-aside for any particular business size or type. The contract...